REDDYNUX fondaparinux sodium 2.5 mg/0.5 mL solution for injection pre-filled syringe

Land: Australien

Språk: engelska

Källa: Department of Health (Therapeutic Goods Administration)

Aktiva substanser:

fondaparinux sodium, Quantity: 2.5 mg

Tillgänglig från:

Dr Reddys Laboratories Australia Pty Ltd

INN (International namn):

Fondaparinux sodium

Läkemedelsform:

Injection, solution

Sammansättning:

Excipient Ingredients: sodium chloride; water for injections

Administreringssätt:

Subcutaneous

Enheter i paketet:

2, 10, 20

Receptbelagda typ:

(S4) Prescription Only Medicine

Terapeutiska indikationer:

Fondaparinux is indicated for the prevention of venous thromboembolic events (VTE) in patients undergoing major orthopaedic surgery of the lower limbs such as hip fracture, major knee or hip replacement surgery.,Fondaparinux is indicated for the prevention of venous thromboembolic events (VTE) in patients undergoing abdominal surgery who are at risk of thromboembolic complications.

Produktsammanfattning:

Visual Identification: Clear and colorless to slightly yellow solution; Container Type: Syringe; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Bemyndigande status:

Licence status A

Tillstånd datum:

2015-02-16